Randy Stephen Coshatt, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 112 5th St Ne, Aliceville, AL 35442 Phone: 205-373-6374 Fax: 205-373-6163 |
News Archive
YM BioSciences Inc., announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab. One of the two trials is in non-small-cell lung cancer (NSCLC) patients who are ineligible for curative treatment and being treated palliatively and the other in patients with brain metastases from NSCLC. Current NSCLC palliative treatment and treatment for brain metastases is radiation alone.
A new study published in the American Heart Association has found that the risk of a heart attack or stroke is reduced later in life in mothers who breastfeed their babies.
Cell and animal studies conducted jointly by scientists at Johns Hopkins, Yale and other institutions have uncovered at least one important contributor to the severe anemia that kills almost half of the 2 million people worldwide who die each year of malaria.
Mayo Clinic researchers have successfully used smaller, folded DNA molecules to stimulate regeneration and repair of nerve coatings in mice that mimic multiple sclerosis (MS). They say the finding, published today in the journal PLoS ONE, suggests new possible therapies for MS patients.
› Verified 2 days ago